Emilia Alors‐Pérez

Dysregulation of the splicing machinery is directly associated to aggressiveness of prostate cancer

Juan M. Jiménez‐Vacas, Vicente Herrero‐Aguayo, Antonio J. Montero‐Hidalgo et al. · EBioMedicine · 2020 · 117 citations · Full text

Medicine, Molecular Biology, Oncology +14

Dysregulation of the Splicing Machinery Is Associated to the Development of Nonalcoholic Fatty Liver Disease

Mercedes del Río-Moreno, Emilia Alors‐Pérez, Sandra González‐Rubio et al. · The Journal of Clinical Endocrinology & Metabolism · 2019 · 102 citations · Full text

Medicine, Pathobiology, Pathology +10

Spliceosome component SF3B1 as novel prognostic biomarker and therapeutic target for prostate cancer

Juan M. Jiménez‐Vacas, Vicente Herrero‐Aguayo, Enrique Gómez‐Gómez et al. · Translational research · 2019 · 77 citations

Medicine, Molecular Biology, Oncology +16

Dysregulated splicing factor SF3B1 unveils a dual therapeutic vulnerability to target pancreatic cancer cells and cancer stem cells with an anti-splicing drug

Emilia Alors‐Pérez, Ricardo Blázquez‐Encinas, Sonia Alcalá et al. · Journal of Experimental & Clinical Cancer Research · 2021 · 58 citations · Full text

Medicine, Cancer Biology, Oncology +17

Changes in Splicing Machinery Components Influence, Precede, and Early Predict the Development of Type 2 Diabetes: From the CORDIOPREV Study

Manuel D. Gahete, Mercedes del Río-Moreno, Antonio Camargo et al. · EBioMedicine · 2018 · 39 citations · Full text

Life Sciences, Molecular Genetics, Molecular Medicine +9